The Relationship Between Obesity and Breast Cancer

Video

Clifford A. Hudis, MD, CEO of the American Society of Clinical Oncology, discusses the significance of the relationship between breast cancer and obesity.

Newsletter

Stay up to date on practice-changing data in community practice.

Subscribe Now!
Recent Videos
Auletta Delves Into the ACCESS Trial and GVHD Prevention
Auletta Delves Into the ACCESS Trial and GVHD Prevention
Real-World Bispecific Antibody Use Post-CAR T in DLBCL
Real-World Bispecific Antibody Use Post-CAR T in DLBCL
Oncotype DX Used for Patients With Breast Cancer to Guide Therapy
Oncotype DX Used for Patients With Breast Cancer to Guide Therapy
Real-World Data Reveal Longer PFS With Elacestrant in Breast Cancer
Real-World Data Reveal Longer PFS With Elacestrant in Breast Cancer
Mitigating Toxicities With Oral SERDs and Other Breast Cancer Therapies
Mitigating Toxicities With Oral SERDs and Other Breast Cancer Therapies
Genomic Differences Impact Real World Use of Elacestrant in Breast Cancer
Genomic Differences Impact Real World Use of Elacestrant in Breast Cancer
Breast Cancer Study Shows Minimal Score Variation After Radiation Boost
Breast Cancer Study Shows Minimal Score Variation After Radiation Boost
Targeting ESR1 Mutations in Breast Cancer With Novel Therapies
Targeting ESR1 Mutations in Breast Cancer With Novel Therapies
Shortened Radiation Trial Advances Breast Cancer Treatment
Shortened Radiation Trial Advances Breast Cancer Treatment
Understanding the Significance of ESR1 Mutations in Breast Cancer
Understanding the Significance of ESR1 Mutations in Breast Cancer
Related Content
AUA 2025: A Sneak Peek for Community Oncologists/Urologists

AUA 2025: A Sneak Peek for Community Oncologists/Urologists

Jordyn Sava
April 22nd 2025
Article

At AUA 2025, experts will present on novel bladder cancer therapies, advanced renal cell carcinoma comparisons, frailty in prostate cancer, and more.

Read More

Behind the FDA Approval of Dato-DXd in HR+/HER2– Breast Cancer With Bardia

Behind the FDA Approval of Dato-DXd in HR+/HER2– Breast Cancer With Bardia

Jordyn Sava;Aditya Bardia, MD, MPH
February 6th 2025
Podcast

In this episode of Targeted Talks, Aditya Bardia, MD, MPH, FASCO, discusses the recent FDA approval of datopotamab deruxtecan in breast cancer.

Listen

Bria-IMT Plus Retifanlimab Shows Promising Survival in HR+ Breast Cancer

Bria-IMT Plus Retifanlimab Shows Promising Survival in HR+ Breast Cancer

Jordyn Sava
April 18th 2025
Article

Phase 2 data suggest a survival benefit with Bria-IMT and retifanlimab in heavily pretreated HR-positive metastatic breast cancer, outperforming historical controls.

Read More

Juneja Explores AI’s Impact in Early Cancer Detection and Treatment

Juneja Explores AI’s Impact in Early Cancer Detection and Treatment

Jordyn Sava;Sanjay K. Juneja, MD
January 15th 2025
Podcast

In this episode of Targeted Talks, Sanjay K. Juneja, MD, discusses the exciting advancements of artificial intelligence in 2024.

Listen

Participants Discuss PI3K Inhibitors and Endocrine Resistance in Metastatic Breast Cancer

Participants Discuss PI3K Inhibitors and Endocrine Resistance in Metastatic Breast Cancer

Targeted Oncology Staff
April 16th 2025
Article

During a a live event, Virginia Kaklamani, MD, DSc, and participants discussed their experiences using a PI3K/AKT inhibitor in patients with metastatic breast cancer.

Read More

FDA Clears ZEISS INTRABEAM 700 for IORT in Cancer Surgery

FDA Clears ZEISS INTRABEAM 700 for IORT in Cancer Surgery

Jordyn Sava
April 9th 2025
Article

The FDA has granted 501(k) clearance to ZEISS INTRABEAM 700, a robotic-assisted platform designed to enhance intraoperative radiation therapy.

Read More